Overcoming Debye screening effect in field-effect transistors for enhanced biomarker detection sensitivity

Area of Science:

• Biomedical Engineering
• Nanoscience
• Analytical Chemistry

Background:

• Field-effect transistor (FET) biosensors enable label-free detection of biomolecules, crucial for disease diagnosis and drug screening.
• Physiological solutions cause Debye screening, where ions shield biomolecule charges, significantly reducing FET sensor sensitivity and reliability.
• Overcoming Debye screening is vital for advancing FET biosensor performance in complex biological samples.

Purpose of the Study:

• To review research progress in overcoming the Debye screening effect in FET-based biosensors over the last decade.
• To elucidate the working principles of FET biosensors and the mechanism of Debye screening.
• To highlight optimization strategies and provide an outlook for developing highly sensitive and stable FET biosensors.

Main Methods:

• Review of scientific literature on FET biosensors and Debye screening.
• Explanation of FET biosensor operation and the Debye screening mechanism.
• Analysis and summarization of various strategies to mitigate Debye screening effects.

Main Results:

• Debye screening significantly hinders FET biosensor performance by weakening the charge induction from biomolecules.
• Various optimization strategies have been developed to counteract the Debye screening effect.
• Progress in overcoming Debye screening promises enhanced sensitivity, specificity, and stability in FET biosensors.

Conclusions:

• Addressing Debye screening is critical for unlocking the full potential of FET biosensors in real-world applications.
• Continued research in this area is expected to drive innovation in next-generation biosensing technologies.
• Optimized FET biosensors will improve disease diagnosis, point-of-care testing, and drug screening capabilities.